Operating Partners

Dylan Jackson

Board Member, Agentis Longevity

Bio

Dylan Jackson currently serves as COO of BrightView, Shore’s addiction treatment platform that has scaled from 4 to 88 locations and ~$220M of revenue. Prior to his time at BrightView, Dylan was a Vice President at Orchard Holdings Group, a private investment firm focused on sustainable long-term growth strategies. Dylan also served in various engineering and project management roles at Procter & Gamble. Dylan earned his B.S. in Chemical Engineering at the University of Cincinnati and his M.B.A. at Harvard Business School.

CURRENT & PAST BOARD ROLES

AREA OF FOCUS

Longevity Health Services